SynthesisBMC urology2026
Predictive value of neutrophil to lymphocyte ratio for the clinical outcome of patients with ureteral stones: a systematic review and meta-analysis.
Synthesis in BMC urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThis study presents the first systematic review and meta-analysis assessing the predictive value of the neutrophil-to-lymphocyte ratio (NLR) on the clinical outcomes in individuals with ureteral stones.
methodsRelevant studies were systematically identified through searches in PubMed, Embase, Web of Science, and Cochrane, covering publications up to January 2025, focusing on studies that assessed the predictive role of NLR in the clinical outcomes of individuals with ureteral stones. Outcomes included spontaneous stone passage (SSP) and ureteric sepsis. Predictive data for SSP were derived from a cohort of patients receiving conservative medical treatment, while predictive data for ureteric sepsis were derived from a cohort of patients receiving surgical treatment. Sensitivity and subgroup analysis were conducted to evaluate the stability of the results and possible sources of heterogeneity.
results10 cohort studies involving 4,859 patients with ureteral stones were analyzed in this meta-analysis. The meta-analysis of multivariate data showed that SSP rate was significantly lower in the high NLR group compared to the low NLR group (OR: 0.46; 95% CI: 0.33, 0.64; P <0.00001), and the risk of ureteric sepsis in the high NLR group was significantly higher than that in the low NLR group (OR: 2.50; 95% CI: 1.31, 4.76; P = 0.005). Subgroup analysis suggested that the prognostic value of NLR for patients with ureteral calculi was not affected by stone size and NLR cut-off value.
conclusionsNLR can be used as an independent predictor of the SSP and the risk of ureteric sepsis in patients with ureteral stones. Future large-scale, multicenter, prospective clinical studies are necessary to further confirm the relationship between NLR and the clinical outcomes of patients with ureteral stones. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.